What is the maximum intravenous dose of furosemide (Lasix) per day in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Intravenous Furosemide Dose Per Day

The maximum single IV dose of furosemide is 160-200 mg per bolus, and while guideline-listed maximums suggest 240 mg in the first 24 hours for acute heart failure, real-world evidence demonstrates that doses up to 600-2000 mg/day can be safely administered in refractory cases with close monitoring, though exceeding 160 mg/day typically signals the need for combination diuretic therapy rather than further dose escalation. 1

Guideline-Based Maximum Dosing

The ACC/AHA guidelines provide the most authoritative framework for IV furosemide dosing:

  • Maximum single bolus dose: 160-200 mg 1
  • Continuous infusion dosing: 40 mg IV load, then 10-40 mg/hour 1
  • First 6 hours limit: <100 mg total dose 2
  • First 24 hours limit: <240 mg total dose 2
  • The guidelines explicitly note that "higher doses may occasionally be used with close monitoring" 1

Real-World Evidence for Higher Doses

While guidelines suggest conservative limits, high-quality research demonstrates safety and efficacy at substantially higher doses:

  • Doses of 500-2000 mg/day have been successfully used in refractory heart failure with mean maintenance doses of 700 mg/day and peak doses reaching 8000 mg/day in one case 3
  • Continuous infusion at rates producing 690 mg/day (range 250-2000 mg) proved more effective than bolus dosing with better sodium excretion and fewer ototoxic effects 4
  • In severe cardiac failure refractory to standard therapy, doses ≥500 mg/day for at least 4 weeks showed improvement in all patients with minimal side effects (gout in 4 patients, tinnitus in 1) 3

Critical Dosing Algorithm

For Standard Acute Heart Failure:

  • Initial dose: 40 mg IV bolus (or equivalent to chronic oral dose) 1, 2
  • Reassess at 2 hours: If urine output <0.5 mL/kg/hour, double the dose 2
  • Maximum escalation: 160-200 mg per bolus 1
  • Do not exceed 240 mg in first 24 hours without adding combination therapy 2

For Refractory Cases:

  • Consider continuous infusion over bolus dosing when doses exceed 160 mg/day 4
  • Infusion protocol: 40 mg load, then 10-40 mg/hour (maximum rate 4 mg/min to prevent ototoxicity) 1, 2
  • Add thiazide or aldosterone antagonist rather than escalating furosemide beyond 160 mg/day 2

Absolute Contraindications to Dose Escalation

Stop furosemide immediately if any of these develop:

  • Systolic blood pressure <90 mmHg without circulatory support 2
  • Severe hyponatremia (sodium <120-125 mEq/L) 2
  • Severe hypokalemia (<3 mEq/L) 2
  • Anuria or progressive renal failure 2
  • Marked hypovolemia (decreased skin turgor, hypotension, tachycardia) 2

Essential Monitoring at High Doses

  • Urine output hourly via bladder catheter (target >0.5 mL/kg/hour) 2
  • Electrolytes within 6-24 hours, then every 1-2 days during titration 2
  • Blood pressure every 15-30 minutes in first 2 hours after high-dose administration 2
  • Renal function within 24 hours of dose escalation 2
  • Ototoxicity monitoring: Doses >250 mg should be given by infusion over 4 hours, not rapid bolus 2

Critical Pitfalls to Avoid

Never use furosemide as monotherapy in acute pulmonary edema—IV nitroglycerin is superior and should be started concurrently, with studies showing reduced intubation rates (13% vs 40%) when nitrates are prioritized 2

Exceeding 160 mg/day signals treatment failure in most contexts—this threshold indicates the need for combination diuretic therapy (hydrochlorothiazide 25 mg, spironolactone 25-50 mg, or metolazone 2.5-5 mg) rather than further furosemide escalation 2

Rapid bolus administration of high doses (>1 mg/kg or ~80 mg) causes reflex vasoconstriction—continuous infusion provides more stable drug levels and better efficacy 4, 2

The first dose produces maximal effect—subsequent doses at the same concentration show up to 25% less efficacy due to compensatory sodium retention mechanisms 2

Special Population Considerations

Chronic Kidney Disease:

  • Maximum single dose: 120-160 mg achieves plateau of dose-response curve in patients with creatinine clearance <20 mL/min 5
  • Higher single doses provide no additional benefit, though more frequent dosing or continuous infusion may be needed 5

Cirrhosis with Ascites:

  • Maximum recommended: 160 mg/day (typically oral, combined with spironolactone 100-400 mg) 2
  • Exceeding 160 mg/day indicates diuretic resistance requiring large-volume paracentesis 2
  • IV administration in cirrhosis should be avoided when possible due to acute GFR reduction risk 2

Ototoxicity Prevention

  • Doses >250 mg must be given by infusion over 4 hours to prevent hearing loss 2
  • Avoid combination with aminoglycosides at high doses due to dramatically increased ototoxicity risk 2
  • Reversible tinnitus occurred in only 1 of 24 patients receiving mean doses of 700 mg/day when administered cautiously 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Furosemide Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

High dose furosemide in refractory cardiac failure.

European heart journal, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.